Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
By: Martina Rebersek, Tanja Mesti, Marko Boc and Janja Ocvirk
Authors
Martina Rebersek
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Tanja Mesti
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Marko Boc
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Janja Ocvirk
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 85 - 95
Submitted on: Aug 30, 2018
Accepted on: Sep 20, 2018
Published on: Mar 3, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.